Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the Disease

NCT02847650 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
57
Enrollment
INDUSTRY
Sponsor class

Stopped Study B7601011 was terminated on 29 Jan 2018 due to lack of efficacy in moderate/advanced Parkinson's disease.

Conditions

Interventions

Sponsor

Pfizer